Skip to main content

previous disabled Page of 14
and
  1. Article

    Open Access

    Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks)

    The randomized phase 2 Neo-peaks study examined usefulness of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) following docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) as compared with th...

    Toshimi Takano, Norikazu Masuda, Mitsuya Ito in Breast Cancer Research and Treatment (2024)

  2. Article

    Open Access

    Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

    Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, Shigenori Nagai in Breast Cancer (2024)

  3. No Access

    Article

    Circulating Exosomal MicroRNA Signature Predicts Peritoneal Metastasis in Patients with Advanced Gastric Cancer

    Despite a radical operation, about half of gastric cancer (GC) patients with advanced GC experience peritoneal metastasis (PM), and the patients with PM have a poor prognosis. However, because staging laparosc...

    Yuma Wada MD, PhD, Masaaki Nishi MD, PhD in Annals of Surgical Oncology (2024)

  4. No Access

    Article

    Prognostic impact of the combination of p16INK4a, p21 and Immunoscore in rectal cancer

    The association between p16INK4a and p21, a marker of cellular senescence, and the Immunoscore, an immunological prognostic indicator, in rectal cancer patients undergoing curative surgery were investigated.

    Toshihiro Nakao, Mitsuo Shimada in International Journal of Clinical Oncology (2024)

  5. Article

    Open Access

    Trastuzumab deruxtecan versus treatment of physician’s choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study

    In the global phase 3 DESTINY-Breast04 study (NCT03734029), the anti-human epidermal growth factor 2 (HER2) antibody–drug conjugate trastuzumab deruxtecan (T-DXd) demonstrated a statistically significant impro...

    Toshinari Yamashita, Joo Hyuk Sohn, Eriko Tokunaga, Naoki Niikura in Breast Cancer (2024)

  6. No Access

    Article

    Prognostic Significance of Sarcopenia and Systemic Inflammatory Markers in Biliary Tract Cancer: A Retrospective Cohort Study

    To evaluate the prognostic significance of sarcopenia and systemic inflammatory markers in patients with surgically resected biliary tract cancer (BTC).

    Masashi Utsumi, Masaru Inagaki, Koji Kitada in Journal of Gastrointestinal Cancer (2024)

  7. Article

    Open Access

    Blue light irradiation inhibits the M2 polarization of the cancer-associated macrophages in colon cancer

    Recent studies have shown that blue light-emitting diode (LED) light has anti-tumor effects, suggesting the possibility of using visible light in cancer therapy. However, the effects of blue light irradiation ...

    Toshiaki Yoshimoto, Masaaki Nishi, Shohei Okikawa, Kozo Yoshikawa in BMC Cancer (2024)

  8. Article

    Open Access

    The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment

    The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition was published in June 2022. The guidelines were prepared while conforming as much as possible to the “Minds Manua...

    Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, Shigenori Nagai in Breast Cancer (2024)

  9. No Access

    Article

    Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1301C (Trigger Study)

    This randomized phase II study explored the superiority of trastuzumab plus S-1 plus cisplatin (SP) over SP alone as neoadjuvant chemotherapy (NAC) for HER2-positive resectable gastric cancer with extensive ly...

    Masanori Tokunaga, Nozomu Machida, Junki Mizusawa, Seiji Ito in Gastric Cancer (2024)

  10. No Access

    Article

    Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse

    The efficacy of high-dose methotrexate (HD-MTX) for central nervous system (CNS) relapse prophylaxis in patients with high-risk diffuse large B-cell lymphoma (DLBCL) is controversial. We compared the prophylac...

    Masahiro Akimoto, Takuya Miyazaki in International Journal of Hematology (2024)

  11. Article

    Open Access

    Role of stromal PD-L1 expression in colorectal liver metastasis

    The outcomes of immune checkpoint blockade for colorectal cancer (CRC) treatment are unsatisfactory. Furthermore, the efficacy of immune checkpoint blockade for liver metastasis of various cancer is poor. Here...

    Chie Takasu, Yuji Morine, Kozo Yoshikawa, Toshihiro Nakao, Takuya Tokunaga in BMC Cancer (2024)

  12. No Access

    Article

    Conversion surgery after successful response to chemotherapy (S-1 + oxaliplatin + nivolumab) in a patient with stage IV gastric cancer with peritoneal metastasis (P1, CY1): a case report

    We here present a case report of a patient with Stage IV gastric cancer with peritoneal metastasis (P1, CY1) who underwent conversion surgery after a successful response to chemotherapy (S-1 + oxaliplatin + ni...

    Takayuki Noma, Masaaki Nishi, Chie Takasu in International Cancer Conference Journal (2024)

  13. No Access

    Article

    Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan

    The influence of the coronavirus disease 2019 (COVID-19) pandemic on the number of newly diagnosed gynecological cancers has not been extensively investigated in Japan. This study determined the impact of COVI...

    Hiroaki Komatsu, Yuji Ikeda, Kei Kawana in International Journal of Clinical Oncology (2024)

  14. Article

    Open Access

    Geriatric nutritional risk index as a prognostic marker of first-line immune checkpoint inhibitor combination therapy in patients with renal cell carcinoma: a retrospective multi-center study

    This study aimed to investigate the effectiveness of the Geriatric Nutritional Risk Index (GNRI) in predicting the efficacy of first-line immune checkpoint inhibitor (ICI) combination therapy for metastatic or...

    Shogo Watari, Satoshi Katayama, Hiromasa Shiraishi, Moto Tokunaga in Discover Oncology (2023)

  15. Article

    Open Access

    The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study

    While PD-L1 expression and neutrophil-to-lymphocyte ratio (NLR) are prognostic biomarkers for lung cancer, few studies have considered their interaction. We hypothesized that the product of PD-L1 expression (t...

    Hironobu Samejima, Kensuke Kojima, Ayako Fujiwara, Toshiteru Tokunaga in BMC Cancer (2023)

  16. No Access

    Article

    Association between ABO blood group/genotype and COVID-19 in a Japanese population

    An association between coronavirus disease 2019 (COVID-19) and the ABO blood group has been reported. However, such an association has not been studied in the Japanese population on a large scale. Little is kn...

    Tatsuya Kusumoto, Shotaro Chubachi, Ho Namkoong, Hiromu Tanaka in Annals of Hematology (2023)

  17. No Access

    Article

    HLA-DQA1*05 and upstream variants of PPARGC1B are associated with infliximab persistence in Japanese Crohn’s disease patients

    Recently, the HLA-DQA1*05 (rs2097432) genetic variation has been reported to be linked to early infliximab (IFX) treatment failure in the Caucasian Crohn’s disease (CD) population, but that evidence is scarce ...

    Fumiko Shimoda, Takeo Naito, Yoichi Kakuta, Yosuke Kawai in The Pharmacogenomics Journal (2023)

  18. Article

    Open Access

    Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocol

    Laparoscopic gastrectomy (LG) is considered a standard treatment for clinical stage I gastric cancer. Nevertheless, LG has some drawbacks, such as motion restriction and difficulties in spatial perception. Rob...

    Rie Makuuchi, Masanori Terashima, Mitsumi Terada, Junki Mizusawa in BMC Cancer (2023)

  19. Article

    Open Access

    Identification of predictive biomarkers for endometrial cancer diagnosis and treatment response monitoring using plasma metabolome profiling

    Endometrial cancer (EMC) is the most common female genital tract malignancy with an increasing prevalence in many countries including Japan, a fact that renders early detection and treatment necessary to prote...

    Eiji Hishinuma, Muneaki Shimada, Naomi Matsukawa, Yoshiko Shima in Cancer & Metabolism (2023)

  20. No Access

    Article

    Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study

    Ovarian serous borderline tumors (SBT) are typically unilateral and are primarily treated using hysterectomy and bilateral sal**ooophorectomy (SO). However, most young patients prefer fertility-sparing surge...

    Tsukasa Baba, Masafumi Koshiyama in International Journal of Clinical Oncology (2023)

previous disabled Page of 14